» Articles » PMID: 35729194

Absence of Causal Association Between Vitamin D and Bone Mineral Density Across the Lifespan: a Mendelian Randomization Study

Overview
Journal Sci Rep
Specialty Science
Date 2022 Jun 21
PMID 35729194
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D deficiency is a candidate risk factor for osteoporosis, characterized by decreased bone mineral density (BMD). We performed this two-sample Mendelian randomization (MR) analysis to investigate the causal effect of vitamin D on BMD. We extracted 143 single-nucleotide polymorphisms from a recent GWAS on 417,580 participants of European ancestry as instrumental variables, and used summary statistics for BMD at forearm (n = 10,805), femoral neck (n = 49,988), lumbar spine (n = 44,731) and total-body of different age-stages (< 15, 15-30, 30-45, 45-60, > 60) (n = 67,358). We explored the direct effect of vitamin D on BMD with an adjusted body mass index (BMI) in a multivariable MR analysis. We found no support for causality of 25-hydroxyvitamin D on BMD at forearm, femoral neck, lumbar spine, and total-body BMD across the lifespan. There was no obvious difference between the total and direct effect of vitamin D on BMD after adjusting for BMI. Our MR analysis provided evidence that genetically determined vitamin D was not causally associated with BMD in the general population. Large-scale randomized controlled trials are warranted to investigate the role of vitamin D supplementation in preventing osteoporosis in the high-risk population.

Citing Articles

Vitamin D3 Release from MgO Doped 3D Printed TCP Scaffolds for Bone Regeneration.

Jo Y, Majumdar U, Bose S ACS Biomater Sci Eng. 2024; 10(3):1676-1685.

PMID: 38386843 PMC: 11186521. DOI: 10.1021/acsbiomaterials.3c01779.


Vitamin D and human health: evidence from Mendelian randomization studies.

Fang A, Zhao Y, Yang P, Zhang X, Giovannucci E Eur J Epidemiol. 2024; 39(5):467-490.

PMID: 38214845 DOI: 10.1007/s10654-023-01075-4.


Targeting Longevity Gene : A Novel Approach to Prevent Age-Related Bone Fragility and Osteoporosis.

Zahn G, Baukmann H, Wu J, Jordan J, Birkenfeld A, Dirckx N Metabolites. 2023; 13(12).

PMID: 38132868 PMC: 10744747. DOI: 10.3390/metabo13121186.


Health Effects of Vitamin D Supplementation: Lessons Learned From Randomized Controlled Trials and Mendelian Randomization Studies.

Bouillon R, LeBoff M, Neale R J Bone Miner Res. 2023; 38(10):1391-1403.

PMID: 37483080 PMC: 10592274. DOI: 10.1002/jbmr.4888.


Investigating the causal relationship between ankylosing spondylitis and osteoporosis in the European population: a bidirectional Mendelian randomization study.

Mei J, Hu H, Ding H, Huang Y, Zhang W, Chen X Front Immunol. 2023; 14:1163258.

PMID: 37359532 PMC: 10285397. DOI: 10.3389/fimmu.2023.1163258.

References
1.
Li S, Gao L, Zhang X, He J, Fu W, Liu Y . Genetically Low Vitamin D Levels, Bone Mineral Density, and Bone Metabolism Markers: a Mendelian Randomisation Study. Sci Rep. 2016; 6:33202. PMC: 5021966. DOI: 10.1038/srep33202. View

2.
Lane N . Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006; 194(2 Suppl):S3-11. DOI: 10.1016/j.ajog.2005.08.047. View

3.
Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R . Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas. 2013; 75(4):392-6. DOI: 10.1016/j.maturitas.2013.05.013. View

4.
Grant W, Whiting S, Schwalfenberg G, Genuis S, Kimball S . Estimated economic benefit of increasing 25-hydroxyvitamin D concentrations of Canadians to or above 100 nmol/L. Dermatoendocrinol. 2016; 8(1):e1248324. PMC: 5129897. DOI: 10.1080/19381980.2016.1248324. View

5.
Jee W . Principles in bone physiology. J Musculoskelet Neuronal Interact. 2005; 1(1):11-3. View